title: The amygdala excitatory/inhibitory balance in a valproate-induced rat autism model.
abstract: The amygdala is an important structure contributing to socio-emotional behavior. However, the role of the amygdala in autism remains inconclusive. In this study, we used the 28-35 days valproate (VPA)-induced rat model of autism to observe the autistic phenotypes and evaluate their synaptic characteristics in the lateral nucleus (LA) of the amygdala. The VPA-treated offspring demonstrated less social interaction, increased anxiety, enhanced fear learning and impaired fear memory extinction. Slice preparation and electrophysiological recordings of the amygdala showed significantly enhanced long-term potentiation (LTP) while stimulating the thalamic-amygdala pathway of the LA. In addition, the pair pulse facilitation (PPF) at 30- and 60-ms intervals decreased significantly. Whole-cell recordings of the LA pyramidal neurons showed an increased miniature excitatory postsynaptic current (EPSC) frequency and amplitude. The relative contributions of the AMPA receptor and NMDA receptor to the EPSCs did not differ significantly between groups. These results suggested that the enhancement of the presynaptic efficiency of excitatory synaptic transmission might be associated with hyperexcitibility and enhanced LTP in LA pyramidal neurons. Disruption of the synaptic excitatory/inhibitory (E/I) balance in the LA of VPA-treated rats might play certain roles in the development of behaviors in the rat that may be relevant to autism. Further experiments to demonstrate the direct link are warranted.
authors: Department and Institute of Physiology, School of Medicine, National Yang-Ming University, Taipei, Taiwan.
authors: Hui-Ching
authors: HC
authors: Lin
authors: Po-Wu
authors: PW
authors: Gean
authors: Chao-Chuan
authors: CC
authors: Wang
authors: Yun-Han
authors: YH
authors: Chan
authors: Po See
authors: PS
authors: Chen
mesh_terms: D000679:Amygdala / Q000503:physiopathology*; D000704:Analysis of Variance; D000818:Animals; D001321:Autistic Disorder / Q000139:chemically induced / Q000378:metabolism*; D003216:Conditioning, Operant; D019706:Excitatory Postsynaptic Potentials / Q000502:physiology*; D005239:Fear / Q000502:physiology; D006652:Histological Techniques; D053444:Inhibitory Postsynaptic Potentials / Q000502:physiology*; D017774:Long-Term Potentiation / Q000502:physiology; D018408:Patch-Clamp Techniques; D051381:Rats; D017207:Rats, Sprague-Dawley; D012919:Social Behavior; D013569:Synapses / Q000502:physiology*; D014635:Valproic Acid / Q000633:toxicity*
chemical_list: D014635:Valproic Acid
references: J Neurosci. 2011 Jun 15;31(24):8851-61
references: 21677169
references: Nat Rev Neurosci. 2010 Jul;11(7):490-502
references: 20559336
references: Behav Neurosci. 2001 Jun;115(3):515-44
references: 11439444
references: Biol Psychiatry. 2006 Aug 15;60(4):322-8
references: 16919522
references: EMBO J. 2011 Jun 03;30(14):2908-19
references: 21642956
references: Curr Opin Neurobiol. 2007 Feb;17(1):43-52
references: 17275284
references: Dev Med Child Neurol. 2005 Aug;47(8):551-5
references: 16108456
references: Eur J Neurosci. 1999 Jun;11(6):1891-8
references: 10336657
references: J Neurosci. 2010 Feb 10;30(6):2115-29
references: 20147539
references: Genes Brain Behav. 2003 Oct;2(5):255-67
references: 14606691
references: Drug Saf. 2006;29(1):1-21
references: 16454531
references: J Am Acad Child Adolesc Psychiatry. 2004 Apr;43(4):481-90
references: 15187809
references: J Neurochem. 2008 Jul;106(2):889-99
references: 18466342
references: J Neurosci. 2011 Sep 14;31(37):13097-109
references: 21917793
references: Neuropsychologia. 2010 Oct;48(12):3665-70
references: 20655320
references: Neuropsychopharmacology. 2008 Mar;33(4):901-12
references: 17507914
references: Prog Brain Res. 2006;156:363-78
references: 17015091
references: Int J Neuropsychopharmacol. 2013 Feb;16(1):91-103
references: 22093185
references: Neuron. 2006 Mar 2;49(5):663-70
references: 16504942
references: J Psychiatr Res. 1990;24(3):251-8
references: 2266513
references: Brain. 1998 May;121 ( Pt 5):889-905
references: 9619192
references: Cell Mol Neurobiol. 2003 Oct;23(4-5):727-38
references: 14514027
references: J Cogn Neurosci. 2008 Dec;20(12):2167-74
references: 18457504
references: Nat Rev Neurosci. 2012 Jan;13(1):3
references: 22295280
references: PLoS One. 2008;3(12):e3892
references: 19065268
references: Nat Rev Neurosci. 2012 Jan 18;13(2):107-20
references: 22251963
references: Neuron. 2007 Aug 16;55(4):545-55
references: 17698008
references: Annu Rev Psychol. 1995;46:209-35
references: 7872730
references: Child Psychiatry Hum Dev. 2005 Fall;36(1):3-26
references: 16049642
references: Soc Cogn Affect Neurosci. 2012 Jan;7(1):11-22
references: 22228751
references: Curr Opin Psychiatry. 2005 Jan;18(1):55-64
references: 16639185
references: J Neurophysiol. 2012 Feb;107(4):1047-57
references: 22090463
references: Biol Psychiatry. 2012 Jul 1;72(1):70-7
references: 22218285
references: Soc Cogn Affect Neurosci. 2007 Dec;2(4):292-302
references: 18985135
references: Nat Neurosci. 2009 Oct;12(10):1226-7
references: 19718035
references: Soc Cogn Affect Neurosci. 2013 Mar;8(3):267-76
references: 22198970
references: J Autism Dev Disord. 2006 Aug;36(6):779-93
references: 16609825
references: Neurosci Biobehav Rev. 2006;30(1):97-117
references: 16157377
references: Psychoneuroendocrinology. 2008 Jul;33(6):728-40
references: 18396377
references: Proc Natl Acad Sci U S A. 2010 Mar 9;107(10):4710-5
references: 20176955
references: Neuroimage. 2012 Apr 15;60(3):1771-7
references: 22289808
references: J Neurosci. 2006 Jul 19;26(29):7674-9
references: 16855095
references: Int J Neuropsychopharmacol. 2010 Apr;13(3):335-45
references: 19775504
references: Cereb Cortex. 2008 Apr;18(4):763-70
references: 17638926
references: Nature. 2011 Jun 22;474(7352):498-501
references: 21697947
references: J Neurophysiol. 2011 Jul;106(1):193-201
references: 21511710
references: Psychopharmacology (Berl). 2007 Sep;193(4):547-55
references: 17497229
references: Biol Psychiatry. 2002 Jan 1;51(1):11-7
references: 11801227
references: Psychoneuroendocrinology. 2009 Feb;34(2):226-237
references: 18849120
references: Neuroimage. 2012 Mar;60(1):179-88
references: 22227133
references: Int J Dev Neurosci. 2005 Apr-May;23(2-3):287-97
references: 15749253
references: Nat Neurosci. 2005 Apr;8(4):519-26
references: 15750588
references: Neural Dev. 2009 May 18;4:17
references: 19450252
references: Neurosci Lett. 1987 Jun 15;77(2):187-92
references: 3601229
references: Nat Neurosci. 2006 May;9(5):636-41
references: 16582902
references: Neuroimage. 2011 Jun 1;56(3):1353-61
references: 21396459
references: Neurology. 1999 Dec 10;53(9):2145-50
references: 10599796
references: Nature. 2008 Oct 16;455(7215):903-11
references: 18923512
references: Nat Neurosci. 2011 Feb;14(2):163-4
references: 21186358
references: Annu Rev Psychol. 2009;60:693-716
references: 18771388
references: Neuropsychopharmacology. 2004 Nov;29(11):2052-64
references: 15199377
references: J Child Psychol Psychiatry. 2006 Mar-Apr;47(3-4):262-76
references: 16492259
references: Proc Natl Acad Sci U S A. 2007 Aug 14;104(33):13501-6
references: 17675408
references: Hum Brain Mapp. 2007 May;28(5):441-9
references: 17133386
references: Neuropsychologia. 2011 Mar;49(4):718-33
references: 20933525
references: Curr Opin Psychiatry. 2005 Jan;18(1):51-4
references: 16639184
references: Neuropsychopharmacology. 2005 Jan;30(1):80-9
references: 15238991
references: Cell. 2000 Jun 9;101(6):657-69
references: 10892652
references: Nature. 2011 Jul 27;477(7363):171-8
references: 21796121
references: Arch Gen Psychiatry. 2006 Dec;63(12):1417-28
references: 17146016
references: Nat Neurosci. 2009 Oct;12(10):1217-8
references: 19783979
references: Neurosci Biobehav Rev. 2000 May;24(3):355-64
references: 10781695
references: J Neurosci. 2008 Jan 2;28(1):68-79
references: 18171924
references: Am J Psychiatry. 2004 Nov;161(11):2038-44
references: 15514404
references: J Neurosci. 1992 Oct;12(10):4066-79
references: 1403101